| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |